VYTRUS BIOTECH EO -01 (F:V5P) — Market Cap & Net Worth
Market Cap & Net Worth: VYTRUS BIOTECH EO -01 (V5P)
VYTRUS BIOTECH EO -01 (F:V5P) has a market capitalization of $63.41 Million (€54.24 Million) as of May 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #20961 globally and #1890 in its home market, demonstrating a 7.46% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying VYTRUS BIOTECH EO -01's stock price €19.45 by its total outstanding shares 6980516 (6.98 Million).
VYTRUS BIOTECH EO -01 Market Cap History: 2022 to 2026
VYTRUS BIOTECH EO -01's market capitalization history from 2022 to 2026. Data shows growth from $27.34 Million to $158.73 Million (51.51% CAGR).
VYTRUS BIOTECH EO -01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how VYTRUS BIOTECH EO -01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of V5P by Market Capitalization
Companies near VYTRUS BIOTECH EO -01 in the global market cap rankings as of May 4, 2026.
Key companies related to VYTRUS BIOTECH EO -01 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
VYTRUS BIOTECH EO -01 Historical Marketcap From 2022 to 2026
Between 2022 and today, VYTRUS BIOTECH EO -01's market cap moved from $27.34 Million to $ 158.73 Million, with a yearly change of 51.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €158.73 Million | +85.24% |
| 2025 | €85.69 Million | +386.11% |
| 2024 | €17.63 Million | -22.86% |
| 2023 | €22.85 Million | -16.42% |
| 2022 | €27.34 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of VYTRUS BIOTECH EO -01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $63.41 Million USD |
| MoneyControl | $63.41 Million USD |
| MarketWatch | $63.41 Million USD |
| marketcap.company | $63.41 Million USD |
| Reuters | $63.41 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About VYTRUS BIOTECH EO -01
Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells in Spain and internationally. The company offers Clarivine that activates skin's regeneration processes; Quora Noni biomics for rejuvenating the skin microbiota; Deobiome Noni, a prebiotic deodorant to reduce the generation of body odour; Sarcoslim Re-Shape, an active ingredient to reduce fat on tissue; Ca… Read more